CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.

Review the current valuation for Regeneron Pharmaceuticals Inc (REGN:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Read about Regeneron Pharmaceuticals Inc (REGN:XNAS) stock and today's latest news and financial updates.